Kernel has published results from its Cybin-sponsored neuroimaging study which show the ability of Kernel’s Flow1 system to capture and analyse brain changes induced by psychedelics.
As their 300-gram MDMA shipment got to the border, PharmAla Biotech found themselves in a sticky situation.
The Psychedelic Access and Research Alliance (PAREA) has released a position statement calling on the EU to harness psychedelics in a bid to create innovation in...
A group of doctors are urging researchers to look at psychedelics to ease the often overwhelming distress faced by women with late-stage gynaecological cancers.
For thousands of years, indigenous societies in Mexico and Central America have used psychedelics for medicinal, spiritual, and cultural purposes.
At PSYCH Symposium in the British Museum on 6 July a conversation between Professor Robin Carhart-Harris and journalist Kate Spicer explored the impact of psychedelic research...
In what marks a positive development for patient access to psychedelic therapies in the US, the American Medical Association has released the language of its first-ever...
In light of clinical research showing MDMA-assisted therapy as a potential treatment for PTSD, at PSYCH Symposium in the British Museum on 6 July a conversation...
At PSYCH Symposium in the British Museum on 6 July, the panel ‘Neuroimaging & Psychedelics: The Past, Present & Future’ explored how neuroimaging can inform our...
PSYCH Symposium’s afternoon panels saw discussions continue the exploration of the landscape of psychedelic healthcare.
